您当前所在位置: 首页 > 学者

刘畅

  • 17浏览

  • 0点赞

  • 0收藏

  • 0分享

  • 57下载

  • 0评论

  • 引用

期刊论文

Celastrol attenuates hypertension-induced inflammation and oxidative stress in vascular smooth muscle cells via induction of heme oxygenase-1

刘畅Yu X. Tao W. Jiang F. Li C. Lin J. & Liu

Am. J. Hypertens. (2010), 23: 895-903.,-0001,():

URL:

摘要/描述

BACKGROUND The aim of this study was to investigate the potential beneficial effects of celastrol, a compound with anti-inflammatory and antioxidant properties, on vascular smooth muscle cells (VSMCs) under hypertensive conditions. METHODS Hypertension was induced in rats by fructose feeding. Hypertensive rats were injected with celastrol, and systolic and diastolic blood pressure were monitored by the tail-cuff method. Insulin sensitivity in animals was measured by GTT. Serum levels of inflammatory cytokines were determined by ELISA. Real-time RT-PCR and Western blot were applied to quantify mRNA and protein levels in tissues and primary cultured VSMCs. Generation of reactive oxygen species (ROS) was measured using lucigenin chemiluminescence for tissue homogenates and DCF-DA staining for VSMC cells. RESULTS Celastrol decreased both systolic and diastolic blood pressure while improving insulin sensitivity in fructose-induced hypertensive rats. Celastrol also inhibited vascular and cardiac hypertrophy. Hypertension augmented circulating and mRNA levels of inflammatory cytokines, and celastrol treatment suppressed their induction. Celastrol also blocked activation of ERK/MAPK and Akt signaling both in vivo and in vitro. More importantly, celastrol increased heme oxygenase-1 (HO-1) expression and activity, whereas zinc protoporphyrin 9 (ZnPP9), a HO-1 inhibitor, partially abolished the beneficial effects of celastrol on hypertensive rats and VSMCs. Finally, ROS generation in tissue homogenates and in VSMCs was reduced by celastrol. CONCLUSIONS These findings suggest that celastrol attenuates hypertension-induced inflammation and oxidative stress in VSMCs via HO-1 induction, and this compound may therefore serve as a novel drug to treat hypertension.

【免责声明】以下全部内容由[刘畅]上传于[2012年04月09日 11时23分18秒],版权归原创者所有。本文仅代表作者本人观点,与本网站无关。本网站对文中陈述、观点判断保持中立,不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考,并请自行承担全部责任。

我要评论

全部评论 0

本学者其他成果

    同领域成果